MX9707009A - Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. - Google Patents

Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.

Info

Publication number
MX9707009A
MX9707009A MX9707009A MX9707009A MX9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A
Authority
MX
Mexico
Prior art keywords
perimenopausal
injectable
month
once
useful
Prior art date
Application number
MX9707009A
Other languages
English (en)
Spanish (es)
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9707009A publication Critical patent/MX9707009A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX9707009A 1995-03-16 1996-03-15 Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. MX9707009A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
PCT/EP1996/001201 WO1996028165A1 (de) 1995-03-16 1996-03-15 Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen

Publications (1)

Publication Number Publication Date
MX9707009A true MX9707009A (es) 1997-11-29

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707009A MX9707009A (es) 1995-03-16 1996-03-15 Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.

Country Status (17)

Country Link
EP (1) EP0814811A1 (ko)
JP (1) JPH11501649A (ko)
KR (1) KR19980703058A (ko)
AR (1) AR002283A1 (ko)
AU (1) AU713258B2 (ko)
CA (1) CA2215382A1 (ko)
CZ (1) CZ289697A3 (ko)
DE (1) DE19510861A1 (ko)
HU (1) HUP9801691A3 (ko)
IL (1) IL117516A (ko)
MX (1) MX9707009A (ko)
NO (1) NO974255L (ko)
NZ (1) NZ304027A (ko)
PL (1) PL322202A1 (ko)
SK (1) SK123997A3 (ko)
WO (1) WO1996028165A1 (ko)
ZA (1) ZA962177B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
IL117516A (en) 2000-07-26
NZ304027A (en) 2000-05-26
HUP9801691A3 (en) 1999-03-01
SK123997A3 (en) 1998-02-04
HUP9801691A2 (hu) 1998-11-30
ZA962177B (en) 1996-07-29
AR002283A1 (es) 1998-03-11
PL322202A1 (en) 1998-01-19
CZ289697A3 (en) 1997-12-17
DE19510861A1 (de) 1996-09-19
EP0814811A1 (de) 1998-01-07
NO974255L (no) 1997-11-14
KR19980703058A (ko) 1998-09-05
WO1996028165A1 (de) 1996-09-19
AU713258B2 (en) 1999-11-25
JPH11501649A (ja) 1999-02-09
NO974255D0 (no) 1997-09-15
CA2215382A1 (en) 1996-09-19
AU5110896A (en) 1996-10-02
IL117516A0 (en) 1996-07-23

Similar Documents

Publication Publication Date Title
NZ234051A (en) Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
DE69710896D1 (en) Progestogen-anti-progestogen therapien
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
IL122109A0 (en) A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
UA48973C2 (uk) Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
EP1319404A3 (de) Mittel zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
GR970100477A (el) Νεα συνθεση
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
BG101349A (en) Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
LU90341I2 (fr) 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
MX9707009A (es) Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
UA41351C2 (uk) Спосіб контрацепції та набір таблеток
HUP9903097A2 (hu) Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted
HC Change of company name or juridical status

Owner name: PFIZER IRELAND PHARMACEUTICALS

MM Annulment or lapse due to non-payment of fees